Hannah Christina Puhr

Medical University of Vienna

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Collaborators (7)

Lorenz Schubert

Medical University of Vienna

Matthias Preusser

Medical University

Matthias Paireder

Head of Department

Severance Hospital

Lisa Gensthaler

Medical University of Vienna

Luzia Berchtold

Medical University of Vienna

Aysegül Ilhan-Mutlu

Medical University of Vienna

Eva Winkler

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hannah Christina Puhr

Research Interests

Explore related searches

Contact this professor

Articles (19)

Collaborators (7)

Lorenz Schubert

Matthias Preusser

Matthias Paireder

Lisa Gensthaler

Luzia Berchtold

Aysegül Ilhan-Mutlu

Eva Winkler

Make your next move.

Hannah Christina Puhr

Research Interests

Explore related searches

Contact this professor

Articles (19)

Response to letter re: Ethnic origin in cancer clinical trials: overrated or understated? A comprehensive analysis of cancer clinical trials leading to FDA and EMA approvals between 2020 and 2022

Ethnic origin in cancer clinical trials: overrated or understated? A comprehensive analysis of cancer clinical trials leading to FDA and EMA approvals between 2020 and 2022

Are we closing the gender gap in academic oncology? An observational study of gender disparities in participant engagement at the ASCO 2024 annual meeting

Lack of association between prior or concurrent malignancies and overall survival in gastroesophageal cancer: evidence from a large European single-center cohort

Lymphovascular Invasion (LVI) Correlates with Systemic Immune-Inflammation Index (SII) in Adenocarcinoma of the Gastroesophageal Junction (AEG): Implications for Prognostic Stratification

Association of family history with patient characteristics and prognosis in a large European gastroesophageal cancer cohort

Correction to: Association of family history with patient characteristics and prognosis in a large European gastroesophageal cancer cohort

Current Landscape of Molecular Biomarkers in Gastroesophageal Tumors and Potential Strategies for Co-Expression Patterns

Overexpression of Fibroblast Growth Factor 8 Is a Predictor of Impaired Survival in Esophageal Squamous Cell Carcinoma and Correlates with ALK/EML4 Alteration

Recent Advances in the Systemic Treatment of Localized Gastroesophageal Cancer

Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma

Innovative strategies in metastatic gastric cancer: a short review

PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study

SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic

Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma

Different Toxicity Profiles Predict Third Line Treatment Efficacy in Metastatic Colorectal Cancer Patients

Viennese risk prediction score for Advanced Gastroesophageal carcinoma based on Alarm Symptoms (VAGAS score): characterisation of alarm symptoms in advanced gastro-oesophageal cancer and its correlation with outcome

Elevated Free Thyroxine Levels Are Associated with Poorer Overall Survival in Patients with Gastroesophageal Cancer: A Retrospective Single Center Analysis

New Treatment Options for Advanced Gastroesophageal Tumours: Mature for the Current Practice?

Collaborators (7)

Lorenz Schubert

Matthias Preusser

Matthias Paireder

Lisa Gensthaler

Luzia Berchtold

Aysegül Ilhan-Mutlu

Eva Winkler

Make your next move.